- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Shukra Pharmaceuticals' board has approved a preferential issue of 46.43 lakh convertible equity warrants to promoter shareholders. These warrants, priced at Rs. 34 each, will raise approximately Rs. 15.79 crore. Investors will pay 25% of the warrant price upfront, with the remaining 75% due upon conversion into equity shares, which can occur within 18 months. This move, awaiting shareholder approval at an Extra Ordinary General Meeting, aims to infuse capital and enhance promoter stake, supporting the company's financial position.